WCM
ABBV icon

Weaver Capital Management’s AbbVie ABBV Stock Holding History

Weaver Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Hold
12,498
– – 0.6% 45
2026
Q1 		$2.72M Buy
12,498
+602
+5% +$134K 0.59% 46
2025
Q4 		$2.72M Buy
11,896
+1,933
+19% +$440K 0.57% 44
2025
Q3 		$2.31M Buy
9,963
+1,698
+21% +$346K 0.5% 51
2025
Q2 		$1.53M Buy
8,265
+25
+0.3% +$4.65K 0.37% 65
2025
Q1 		$1.73M Buy
8,240
+310
+4% +$60.3K 0.46% 60
2024
Q4 		$1.41M Buy
7,930
+2,318
+41% +$426K 0.39% 70
2024
Q3 		$1.11M Buy
5,612
+1,993
+55% +$372K 0.33% 85
2024
Q2 		$621K Buy
3,619
+2,418
+201% +$401K 0.2% 100
2024
Q1 		$219K Buy
+1,201
New +$207K 0.07% 141

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Weaver Capital Management's ABBV Position: Q2 2026 in Review

Weaver Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 12,498 shares worth $2.72M. The position accounts for 0.6% of the portfolio, ranked #45.

Weaver Capital Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Weaver Capital Management held 12,498 shares of AbbVie worth $2.72M as of Q2 2026.
  • Weaver Capital Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.6% of Weaver Capital Management's portfolio in Q2 2026, its #45 holding.
  • Weaver Capital Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Weaver Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.